Patent Assignment
Reel/Frame 061882/0708
Security Agreement (First Lien)
Recorded: 2022-11-04
Pages: 15
Assignors
BAUSCH HEALTH COMPANIES INC.
Executed: 2022-10-31
BAUSCH HEALTH IRELAND LIMITED
Executed: 2022-10-31
SOLTA MEDICAL IRELAND LIMITED
Executed: 2022-10-31
Assignee
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(160)
Methods of Treating Nonalcoholic Fatty Liver Disease (Nafld) Using Il-17RA Antibody
Application:
17/642,130 →
Publication:
US US20220380449A1
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Stabilized Efinaconazole Compositions as Antifungals
Anti-Infective Methods, Compositions, and Devices
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Compositions and Methods for Treating Diseases of the Nail
Application:
17/092,473 →
Publication:
US US20210121572A1
Compositions and Methods for Treating Diseases of the Nail
Topical Pharmaceutical Compositions for Treating Skin Conditions
Application:
17/714,090 →
Publication:
US US20220226271A1
Polymeric Emulsion Delivery Systems
Application:
17/747,938 →
Publication:
US US20230000768A1
Topical Compositions and Methods for Treating Acne Vulgaris
Application:
16/822,831 →
Publication:
US US20200297684A1
Topical Compositions
Topical Compositions Comprising a Macrolide Immunosuppressant
Application:
17/814,474 →
Publication:
US US20220362232A1
Formulations of Calcium and Phosphate for Oral Inflammation
Liquid Oral Dosage Formulations of Methylnaltrexone
Application:
17/495,413 →
Publication:
US US20220096461A1
Use of Methylnaltrexone and Rifaximin for Treatment of Increased Gut Permeability or Associated Disorders
Application:
17/529,818 →
Publication:
US US20220175764A1
Rifaximin Liquid Formulations
Methods of Using Rifamycin Sv for the Treatment of Sickle Cell Disease
Application:
17/687,534 →
Publication:
US US20220280478A1
Ultrasonic Probes for Producing Multiple Cavitation Volumes
Electrode Assemblies with Non-Contact Temperature Sensing for Thermal Measurements
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Application:
17/207,222 →
Publication:
US US20210205406A1
Agonists of Guanylate Cyclase and Their Uses
Application:
17/184,256 →
Publication:
US US20210379142A1
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Application:
17/397,796 →
Publication:
US US20220119449A1
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
16/882,059 →
Publication:
US US20200283480A1
Topical Compositions and Methods for Treating Skin Diseases
Application:
16/179,576 →
Publication:
US US20190133943A1
Topical Compositions and Methods for Treating Psoriasis
Topical Compositions and Methods for Treating Psoriasis
Topical Compositions and Methods for Treating Skin Diseases
Ceramic Applicator for Transcutaneous Delivery of Energy
Microblade Structure and Method of Treating Tissue
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Pain Mitigation by Mechanical Stimulation When Treating Tissue with Electromagnetic Energy
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Vented Tip
Patent:
970,741 →
Application:
29/763,116 →
Photopolymerization Material for Gums Isolation
Teeth Whitening Composition and Methods
Compositions and Methods for Teeth Whitening
Methods for Effecting Regression of Tumor Mass and Size in a Metastasized Pancreatic Tumor
Stereoselective Synthesis of Metyrosine
Stereoselective Synthesis of Metyrosine
Modified Release Formulations of a Bupropion Salt
Modified-Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Bupropion Hydrobromide and Therapeutic Applications
Bupropion Hydrobromide and Therapeutic Applications
Bupropion Hydrobromide and Therapeutic Applications
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations Of A Bupropion Salt
Bupropion Hydrobromide Polymorphs
Bupropion Hydrobromide Polymorphs
Controlled Release Dosage Forms
Controlled Release Dosage Forms
Modified Release Tablet of Bupropion Hydrochloride
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Stabilized Efinaconazole Compositions
Stabilized Efinaconazole Compositions
Stabilized Efinaconazole Formulations
Anti-Infective Methods, Compositions, and Devices
Anti-Infective Methods, Compositions, and Devices
Method for Stabilizing Polypeptides Lacking Methionine
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Suspension Containing Micronized Benzoyl Peroxide
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Kinetin/Zeatin Topical Formulation
Kinetin/Zeatin Topical Formulation
Kinetin/Zeatin Topical Formulation
Compositions and Methods for Treating Diseases of the Nail
Patent:
8,039,494 →
Application:
12/803,848 →
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Alpha Hydroxy Acid Sustained Release Formulation
Topical Pharmaceutical Compositions for Treating Skin Conditions
Topical Pharmaceutical Compositions for Treating Skin Conditions
Polymeric Emulsion Delivery Systems
Topical Compositions
Granular Sustained Release Preparation and Production Thereof
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Process of Preparing Guanylate Cyclase C Agonists
Process of Preparing Guanylate Cyclase C Agonisys
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Compositions Useful For The Treatment Of Gastrointestinal Disorders
Compositions Useful for the Treatment of Gastrointestinal Disorders
Agonists of Guanylate Cyclase and Their Uses
Agonists of Guanylate Cyclase and Their Uses
Agonists of Guanylate Cyclase and Their Uses
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations and Methods for Treating Ulcerative Colitis
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists Of Guanylate Cyclase And Their Uses
Agonists of Guanylate Cyclase and Their Uses
Agonists of Guanylate Cyclase and Their Uses
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Methods for manufacturing phenoxyethanol
Multidose Package, Course and Method of Treatment for Delivering Predetermined Multiple Doses of a Pharmaceutical
Topical Compositions and Methods for Treating Psoriasis
Topical Compositions and Methods for Treating Psoriasis
Topical Compositions and Methods for Treating Skin Diseases
Encrypted Memory Device
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Light Therapy Device
Patent:
921,212 →
Application:
29/720,106 →
Light Therapy Device
Patent:
959,003 →
Application:
29/780,736 →
Light Therapy Device
Patent:
922,595 →
Application:
29/720,107 →
Light Therapy Device
Patent:
928,975 →
Application:
29/720,109 →
Light Therapy Device
Patent:
959,004 →
Application:
29/788,730 →
Access Device
Patent:
940,133 →
Application:
29/720,111 →
Display Screen with Animated Graphical User Interface
Patent:
959,458 →
Application:
29/782,587 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Release Agreement
Mar 14, 2011
From: GOLDMAN SACHS LENDING PARTNERS LLC
To: BIOVAIL INTERNATIONAL LABORATORIES SRL; BIOVAIL INTERNATIONAL LABORATORIES (BARBADOS) SRL
Reel/Frame 025950/0073 →
Change in Name and Country of Incorporation
Aug 9, 2012
From: VALEANT INTERNATIONAL (BARBADOS) SRL
To: VALEANT INTERNATIONAL BERMUDA
Reel/Frame 028757/0052 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Assignment of Assignor's Interest
Nov 19, 2015
From: INVADO PHARMACEUTICALS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 037089/0440 →
Assignment of Assignor's Interest
Nov 19, 2015
From: WELDON, BARTHOLOMEW; KOBUS, EDWARD; DUMOULIN, SANDRYNE; BETANCOURT, AIMESTHER
To: INVADO PHARMACEUTICALS LLC
Reel/Frame 037089/0309 →
Security Interest
Jul 18, 2016
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039380/0385 →
Security Interest
Jul 19, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043045/0959 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Assignment of Assignor's Interest
May 23, 2018
From: ANGEL, ARTURO; DOW, GORDON
To: DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 045887/0620 →
Security Interest
Aug 10, 2018
From: BAUSCH & LOMB INCORPORATED; DOW PHARMACEUTICAL SCIENCES, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 046616/0301 →
Security Interest
Aug 10, 2018
From: BAUSCH & LOMB INCORPORATED; DOW PHARMACEUTICAL SCIENCES, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA; MEDICIS PHARMACEUTICAL CORPORATION
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 046616/0261 →
Assignment of Assignor's Interest
Oct 29, 2018
From: ANGEL, ARTURO; DOW, GORDON
To: DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 047344/0731 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Assignment of Assignor's Interest
Jun 26, 2019
From: DOW PHARMACEUTICALS SCIENCES, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 049592/0460 →
Assignment of Assignor's Interest
Jun 26, 2019
From: DOW PHARMACEUTICALS SCIENCES, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 049591/0962 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest
Aug 26, 2019
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH, CANADA INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 050169/0636 →
Security Interest
Aug 26, 2019
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH, CANADA INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 050169/0623 →
Assignment of Assignor's Interest
Apr 29, 2020
From: CHANG, YUNIK; DOW, GORDON J.; PILLAI, RADHAKRISHNAN
To: DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 052524/0836 →
Security Interest
May 6, 2020
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, LTD; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 052589/0884 →
Security Interest
May 6, 2020
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, LTD; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 052589/0813 →
Assignment of Assignor's Interest
Oct 5, 2020
From: PILLAI, RADHAKRISHNAN; DOW, GORDON
To: DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 053973/0592 →
Assignment of Assignor's Interest
Nov 9, 2020
From: WINCKLE, GARETH; FIELDSON, GREGORY T.
To: DOW PHARMACEUTICAL SCIENCES, INC.
Reel/Frame 054310/0754 →
Security Interest
Mar 29, 2021
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 055756/0281 →